MBIO MUSTANG BIO, INC.

Nasdaq mustangbio.com


$ 1.49 $ -0.02 (-1.32 %)    

Friday, 17-Oct-2025 15:59:55 EDT
QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 1.5
$ 1.52
$ 1.45 x 2
$ 1.68 x 82
$ 1.45 - $ 1.52
$ 0.89 - $ 21.95
79,499
na
10.86M
$ 1.61
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2025 06-30-2025 10-Q
2 05-14-2025 03-31-2025 10-Q
3 03-28-2025 12-31-2024 10-K
4 11-08-2024 09-30-2024 10-Q
5 08-13-2024 06-30-2024 10-Q
6 05-15-2024 03-31-2024 10-Q
7 03-11-2024 12-31-2023 10-K
8 11-14-2023 09-30-2023 10-Q
9 08-14-2023 06-30-2023 10-Q
10 05-12-2023 03-31-2023 10-Q
11 03-30-2023 12-31-2022 10-K
12 11-14-2022 09-30-2022 10-Q
13 08-11-2022 06-30-2022 10-Q
14 05-12-2022 03-31-2022 10-Q
15 03-23-2022 12-31-2021 10-K
16 11-12-2021 09-30-2021 10-Q
17 08-16-2021 06-30-2021 10-Q
18 05-14-2021 03-31-2021 10-Q
19 03-24-2021 12-31-2020 10-K
20 11-06-2020 09-30-2020 10-Q
21 08-10-2020 06-30-2020 10-Q
22 05-11-2020 03-31-2020 10-Q
23 03-16-2020 12-31-2019 10-K
24 11-12-2019 09-30-2019 10-Q
25 08-09-2019 06-30-2019 10-Q
26 05-10-2019 03-31-2019 10-Q
27 03-18-2019 12-31-2018 10-K
28 11-13-2018 09-30-2018 10-Q
29 08-13-2018 06-30-2018 10-Q
30 05-14-2018 03-31-2018 10-Q
31 03-29-2018 12-31-2017 10-K
32 11-14-2017 09-30-2017 10-Q
33 08-14-2017 06-30-2017 10-Q
34 05-15-2017 03-31-2017 10-Q
35 03-31-2017 12-31-2016 10-K
36 11-14-2016 09-30-2016 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 calidi-biotherapeutics-stock-jumps-39-after-hours--whats-going-on

Calidi Biotherapeutics (NYSE: CLDI) surged 39.47% after hours Tuesday, following renewed investor interest in its innovative ca...

 mustang-bio-mbio-stock-explodes-260-after-fda-grants-key-cancer-drug-designation

Mustang Bio shares are trading sharply higher Monday afternoon. The FDA granted Orphan Drug Designation to its cell therapy, MB...

 why-greenbrier-shares-are-trading-higher-by-over-13-here-are-20-stocks-moving-premarket

Shares of The Greenbrier Companies, Inc. (NYSE: GBX) rose sharply in today's pre-market trading after the company posted st...

 mustang-bio-receives-fda-orphan-drug-designation-for-mb-101-treatment-of-malignant-glioma

https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=1082425

 mustang-bio-designated-orphan-designation-status-for-an-autologous-ex-vivo-expanded-cluster-of-differentiation-62-enriched-naive-and-memory-t-cell-investigational-product-that-has-been-genetically-modified-using-a-self-inactivating-lentiviral-vector-to-express-an-il13ralpha2-targeted-hinge-optimized-4-1bb-costimulatory-chimeric-antigen-receptor-with-a-truncated-cd19-for-the-treatment-of-malignant-glioma

https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=1082425

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION